IMPORTANT ANNOUNCEMENTS

FICPI BLOG

COMMENTARY AND VIEWS FROM THE IP WORLD

A good night for Neurim Pharmaceuticals - Assistant Commissioner Luiten as an agent for controlling the release of an examined patent application

Neurim Pharmaceuticals was unsuccessful in overcoming the examiner’s repeated objections to its New Zealand patent application, but the application will be accepted subject to generous amendments directed by Assistant Commissioner Luiten.